Trending...
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4 - 131
- Visit Local Farms During 7th Annual Santa Barbara County Farm Day - 119
- AI Transforming the POD Industry: Innovations and Opportunities - 108
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.
TEMECULA, Calif. - Californer -- Jellyfish Publication-Certified Nutraceuticals, Inc.
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on The Californer
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on The Californer
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on The Californer
- California: Governor Newsom celebrates four years of connecting education and workforce insights thanks to Cradle-to-Career
- MIDIGEN Launches Free AI-Powered Melody Generator for Musicians and Producers
- Block AI Labs Empowers Startups with Affordable, AI-Driven Software Development from U.S. and Colombia Ask ChatGPT
- California: Governor Newsom announces appointments 7.25.25
- California: Governor Newsom meets with Texas state leaders amid Republican efforts to gerrymander state to let Trump keep wielding power without restraint
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on The Californer
- Local SoCal Business Powers FIFA World Cup Launch with Live Custom Jersey Printing at Fox Studios
- Lifetime Montessori School Unveils "The Montessori Podcast" – A Guiding Resource for Parents
- Long Beach Public Library Locations to Temporarily Close for Staff Training on Wednesday, August 27
- Lifetime Montessori School Now Training the Next Generation of Montessori Teachers
- New report shows Cap-and-Invest dollars are improving air quality in California's most polluted communities
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals, Inc.
0 Comments
Latest on The Californer
- iRobot Corporation (IRBT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Swim Up Hill, Diversity in Aquatics, and Inglewood Host Movie Night Celebrating Aquatic Equity
- Macon's Historic Douglass Theatre Names Toni Simmons Henson as Artistic Director for Inaugural Series Celebrating the Spirit of American Theatre
- LACI Presents Reframe Systems with $25,000 Grand Prize for LA Resilient Rebuilding Cup; Prize Funding to Support Innovation Pilots Including to Reduce Cost, Time to Rebuild Resilient and Sustainable Homes in Fire-Affected Communities in Greater Los Angele
- Natural Field Celebrates 20th Anniversary, Advancing Functional Ingredients Globally
- Socket Mobile Announces Second Quarter 2025 Results Release Date and Conference Call
- THE LEGO GROUP UNVEILS "SAN DIEGO LEGO®-CON" AT SAN DIEGO COMIC-CON 2025
- Anern Shines at SOLAR AFRICA 2025 with Integrated Solar + Storage Solutions
- 'The Tech Neck Epidemic: How Screen Time Is Negatively Impacting Our Spine,' Says Auburn Chiropractor Dr. Gordon Fimreite
- Parks, Recreation and Marine to Induct Two New Members into Long Beach Golf Hall of Fame
- Comedian Marc Yaffee Comes To Cloverdale August 23
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4
- Max Life Agency taking part in PHP Takeoff event in Las Vegas Featuring Coach K and Ray Lewis
- Quinceañera Expo Returns to San Pedro – August 24, 2025 at the DoubleTree by Hilton!
- Airbnb to Announce Second Quarter 2025 Results
- California: Governor Newsom announces local progress in reducing homelessness
- California predeploys resources in Nevada, Plumas, and Sierra counties ahead of critical fire weather conditions
- Swim Mobile and LAUSD Launch California's Largest School-Based Swim Equity Project
- AI Transforming the POD Industry: Innovations and Opportunities
- Visit Local Farms During 7th Annual Santa Barbara County Farm Day